Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10640923.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Linear IgA bullous dermatosis (LABD) is an autoimmune, subepidermal, vesiculobullous disease that has been commonly associated with the use of vancomycin hydrochloride. Lesions typically appear during vancomycin therapy, 24 hours to 15 days after the first dose. A 65-year-old white man with renal insufficiency developed pruritic, tense bullae on the right chest, right medial arm, right flank, abdomen, and right upper thigh 14 days after his last dose of vancomycin. Histopathologic examination and immunofluorescence studies were diagnostic of LABD. Vancomycin-related LABD may appear as long as 2 weeks after the drug is discontinued.
Medical subject headings
- Anti-Bacterial Agents
- Autoimmune Diseases
- Immunoglobulin A
- Renal Insufficiency
- Skin Diseases, Vesiculobullous
- Substance Withdrawal Syndrome
- Vancomycin